J Mark Levin

Affiliations

  • Large Shareholder at Jounce Therapeutics Inc. (JNCE), 2021-11-17
  • Large Shareholder, Director at Fulcrum Therapeutics Inc. (FULC), 2021-11-12
  • Large Shareholder at Revolution Medicines Inc. (RVMD), 2021-06-07
  • Large Shareholder, Director at Voyager Therapeutics Inc. (VYGR), 2021-06-04
  • Large Shareholder at Nurix Therapeutics Inc. (NRIX), 2021-05-10
  • Large Shareholder at Decibel Therapeutics Inc. ([DBTX]), 2021-02-12
  • Large Shareholder at Relay Therapeutics Inc. (RLAY), 2021-01-15
  • Large Shareholder at Pliant Therapeutics Inc. (PLRX), 2020-06-10
  • Large Shareholder at Rhythm Pharmaceuticals Inc. (RYTM), 2018-09-04
  • Large Shareholder at Constellation Pharmaceuticals Inc (CNST), 2018-08-24
  • Large Shareholder at Neon Therapeutics Inc. (NTGN), 2018-07-03
  • Large Shareholder at Myokardia Inc (MYOK), 2018-03-07
  • Large Shareholder at Allena Pharmaceuticals Inc. (ALNA), 2017-11-06
  • Large Shareholder at Cytomx Therapeutics Inc. (CTMX), 2017-10-19
  • Large Shareholder at Global Blood Therapeutics Inc. (GBT), 2017-06-16
  • Large Shareholder at Blueprint Medicines Corp (BPMC), 2017-03-20
  • Large Shareholder at Sage Therapeutics Inc. (SAGE), 2016-08-19
  • Large Shareholder at Editas Medicine Inc. (EDIT), 2016-08-16
  • Large Shareholder at Zafgen Inc. (ZFGN), 2015-07-24
  • Large Shareholder at Foundation Medicine Inc. (FMI), 2015-05-15
  • Director at Eleven Biotherapeutics Inc. (EBIO), 2014-03-24
Insider Trading: Purchases See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
FULC $16.00 81,250 Large Shareholder, Director 5,962,202 2019-07-22 Filing
Insider Trading: Sales See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
BPMC $41.55 5,200 Large Shareholder 111,244 2017-03-16 Filing
BPMC $40.74 24,800 Large Shareholder 116,444 2017-03-16 Filing